Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Glioma 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Astrocytoma 3 Sarcoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Lung Neoplasms 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Skin Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Rhabdomyosarcoma 1 Recurrence 1 Radiation Injuries 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Pilonidal Sinus 1

Interventions

Specimen Handling 3 Doxorubicin 3 Biopsy 3 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 toripalimab 1 talimogene laherparepvec 1 ribociclib 1 peposertib 1 pazopanib 1 liposomal doxorubicin 1 cabozantinib 1 abemaciclib 1 Temozolomide 1 Surgical Procedures, Operative 1 PM 01183 1 Nivolumab 1 Neoadjuvant Therapy 1 Ifosfamide 1 Everolimus 1 Docetaxel 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Surgical Procedures, Operative × 90 days × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡